(pdf descarcable al realizar el pago).

This technology can be applied to multiple sectors:
1) Lens coating (hydrophobicity, self-cleaning).
2) Coating of electrodes for fuel cells, batteries, capacitors and electrolyzers.
3) Coating of sensors and biosensors.
4) Coating of implants and prosthesis.
5) RF device coating.

Wide variety of nanostructures: pure nanoparticles, alloys, metal oxides, core-shell and nanocolumns. Control of size, composition and distribution. No residues generated in the coating process. Without any impurity or ligand.

*Contact us to customize your surfaces.

*Shipping: 20 business days from receipt of the devices.
*Price: From 1,500€ (The price varies depending on the size of the devices to be coated, number of devices, amount of nanoparticles and composition).

*contact us for further details.

Training Platform for surgical environments using virtual and mixed reality for the simulation of hyper-realistic scenarios

The Genesys V1 bioreactor is the ultimate tool for R&D laboratories that carry out bioprocesses such as precision fermentation.

The equipment's excellent price-performance ratio allows users to benefit from advanced control and monitoring technology during the fermentation process at a low cost. The Genesys V1 consists of a control unit with a touch screen, as well as five peristaltic pumps for greater process versatility, and a reactor unit with high-precision Hamilton sensors. Control features: Temperature control by pumping hot and cold water to the vessel jacket. pH control by controlled pumping of acid and base. Foam control by controlled pumping of antifoaming agent. PO2 control by agitation and oxygenation system by pumping ambient air (optional use of pure oxygen by connecting to an O2 cylinder with a 1 bar regulator).

Programmable and automatic batch feeding control using high-precision pumping and automatic flow rate calculation. Control of filling, emptying, and sampling by pumping. Other features: Tool-free sensor mounting and removal system. Magnetic mounting and removal system for agitator/oxygenator.

Agitator with integrated oxygenation system. Includes bottle holder on the rear. Integrated temperature control pumps (multiple bioreactors can be supplied with water at 15°C and 83°C from the same low-cost cooling and heating station). Integrated air pumping system (no external gas cylinders required).

*Special delivery times may apply to this product. Please, contact us for details.

*For Research Use Only.

- wild-type endothelial cells.
- tumor cells.

Aprox. 500.000 cells.

(pdf descargable durante el proces de pago).
Anuario con los principales eventos de inversión durante el año 2024.

PARTE I / PART I
ESTUDIOS DOCTRINALES SOBRE CAPITAL RIESGO
(VENTURE CAPITAL AND PRIVATE EQUITY ACADEMIC RESEARCH)
Financiación de startups, colaboración público-privada y capital riesgo
(Startup financing, public-private partnership and venture capital)
Rodrigo Recondo Porrúa ........................................................................... 11

Consideraciones sobre la finalidad y contenido de la Directiva 2024/2810 relativa a estructuras de acciones con derechos de voto múltiple
*(Considerations on the purpose and content of Directive 2024/2810 on share structures with multiple voting rights)*
Benjamín Peñas Moyano ............................................................................ 67

La Directiva sobre diligencia debida: jugando a lo incierto
(The Corporate Sustainability Due Diligence Directive: playing with the uncertain)
David Ramos Muñoz y Juan Manuel Ramírez Cirera ..................... 101

Las inversiones sostenibles: su marco normativo profuso, confuso y difuso
(Sustainable Investments: Its Profuse, Confusing and Diffuse Legal Framework)
Luis Sirimarco Diez-Picazo ....................................................................... 147

PARTE II / PART II
ANÁLISIS DEL MERCADO DE CAPITAL RIESGO
(PRIVATE EQUITY AND VENTURE CAPITAL SPANISH MARKET. SURVEY 2024)
El mercado español de capital riesgo en 2024
(Private Equity and Venture Capital Spanish Market. Survey 2024)
Miguel Recondo Zabala .............................................................................. 185

Panorama de la industria de capital privado en Latinoamérica
(Evolution of the private equity fund industry in Latin America)
Asociación Colombiana de Fondos de Capital Privado ................... 267

Private Equity Portuguese Market Annual Report 2024
(Informe anual del mercado portugués de private equity en 2024)
Diana Ribeiro Duarte y Pedro Capitao Barbosa .................................. 293

Personalized blood test that combines advanced Nuclear Magnetic Resonance (NMR) for metabolomic analysis to provide a comprehensive and personalized evaluation of an individual’s metabolic health.

Using a drop of your own blood sample, this test quantifies a range of low-molecular-weight metabolites related to lipid metabolism, energy balance, amino acid metabolism, glycolysis, and ketone body production. These results are then compared against a reference population of over 6,000 healthy individuals, allowing for the calculation of a global metabolic health score, a metabolic age compared to chronological age, and detailed scores across key metabolic domains.

The report includes personalized recommendations to support lifestyle changes and health optimization. Designed for research and monitoring purposes, MetBalance is particularly useful in preventive health programs, clinical studies, and lifestyle intervention follow-up. It empowers healthcare professionals and individuals alike to better understand metabolic function, detect early imbalances, and take proactive steps toward improving long-term metabolic well-being.

Ideal for:
✔️ Individuals willing to monitor or improve their health
✔️ Preventive health programs and lifestyle change follow-up
✔️ Sports performance and recovery tracking
✔️ Nutritionists, trainers, and wellness professionals

Advanced Lipoprotein Profiling by Nuclear Magnetic Resonance.
It consists on CE-marked test, using in vitro diagnostic tool that leverages nuclear magnetic resonance (NMR) spectroscopy to provide a detailed, quantitative characterization of lipoprotein particles, including their size, number, and subclass distribution across the main lipoprotein classes: VLDL, LDL, and HDL.

Unlike conventional lipid panels that measure only total cholesterol and triglyceride concentrations, Liposcale offers advanced lipoprotein profiling that enables clinicians and researchers to gain a deeper understanding of a patient’s cardiovascular and metabolic risk profile.

This includes the quantification of small dense LDL particles and other parameters associated with atherosclerotic risk and insulin resistance, which are often overlooked in routine clinical testing. The Liposcale test plays a valuable role in precision medicine, particularly in the early detection and monitoring of cardiometabolic diseases, where detailed lipoprotein metrics can support personalized prevention and treatment strategies.

It is especially useful in individuals with metabolic disorders, residual cardiovascular risk despite normal lipid values, or those undergoing lifestyle or pharmacological interventions.

✔️ CE-IVD certified
✔️ High reproducibility and scalability
✔️ Ready for integration in clinical workflows and research pipelines